Importin-7, noted to be upregulated in the AP + AG treated group, is involved in the nuclear import of ribosomal proteins and its elevation in cancer indicates a disruption in ribosome formation, leading to the activation of the tumor suppressor protein P53 (Golomb et al., 2012). This evidence concerns the gene IPO7 and cancer.